Amneal Pharma and theAIDilemma: Balancing Innovation with Emerging Risksand Regulations
Amneal Pharma confronts mounting challenges asartificial intelligence-based platforms invite a plethora ofrisks.AI'sautonomous nature not only …
Read the original at TipRanks.com ↗
- Topics
- HealthcareRegulation & Policy
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”